1.
Modeling the economic and health consequences of managing chronic osteoarthritis pain with opioids in Germany: comparison of extended-release oxycodone and OROS hydromorphone
by Ward, Alexandra
Current medical research and opinion, 2007, Vol.23 (10), p.2333-2345
2.
Comparing the Effect of Tampering on the Oral Pharmacokinetic Profiles of Two Extended‐Release Oxycodone Formulations with Abuse‐Deterrent Properties
by Gudin, Jeff
Pain medicine (Malden, Mass.), 2015, Vol.16 (11), p.2142-2151
3.
Changes in Prevalence of Prescription Opioid Abuse after Introduction of an Abuse‐Deterrent Opioid Formulation
by Cassidy, Theresa A.
Pain medicine (Malden, Mass.), 2014, Vol.15 (3), p.440-451
4.
In-hospital postoperative opioid use and its trends in neurosurgery between 2007 and 2018
by Rautalin, Ilari
Acta neurochirurgica, 2021, Vol.164 (1), p.107-116
5.
A randomized, double-blind, phase III study comparing multiple doses of tapentadol IR, oxycodone IR, and placebo for postoperative (bunionectomy) pain
by Daniels, Stephen E
Current medical research and opinion, 2009, Vol.25 (3), p.765-776
6.
Safety and efficacy of oxycodone/naloxone vs. oxycodone vs. morphine for the treatment of chronic low back pain: results of a 12 week prospective, randomized, open-label blinded en...
by Ueberall, Michael A
Current medical research and opinion, 2015, Vol.31 (7), p.1413-1429
7.
Treatment With Prolonged-Release Oxycodone/Naloxone Improves Pain Relief and Opioid-Induced Constipation Compared With Prolonged-Release Oxycodone in Patients With Chronic Severe P...
by Poelaert, Jan, MD, PhD
Clinical therapeutics, 2015, Vol.37 (4), p.784-792
8.
Polymer-mediated delivery of vaccines to treat opioid use disorders and to reduce opioid-induced toxicity
by Gradinati, Valeria
Vaccine, 2020, Vol.38 (30), p.4704-4712
9.
An abuse-deterrent, microsphere-in-capsule formulation of extended-release oxycodone: alternative modes of administration to facilitate pain management in patients with dysphagia
by McCarberg, Bill H.
Current medical research and opinion, 2016, Vol.32 (12), p.1975-1982
10.
Oxycodone: a review of its use in the management of pain
by Riley, Julia
Current Medical Research and Opinion, 2008, Vol.24 (1), p.175-192
11.
Efficacy and tolerability of tapentadol immediate release and oxycodone HCl immediate release in patients awaiting primary joint replacement surgery for end-stage joint disease: A...
by Hartrick, Craig, MD
Clinical therapeutics, 2009, Vol.31 (2), p.260-271
12.
Impact of Prolonged-release Oxycodone/Naloxone on Outcomes Affecting Patients' Daily Functioning in Comparison With Extended-release Tapentadol: A Systematic Review
by Thakur, Deepika, MPharm
Clinical therapeutics, 2015, Vol.37 (1), p.212-224
13.
Hydrocodone is More Effective than Morphine or Oxycodone in Suppressing the Development of Burn-Induced Mechanical Allodynia
by Emery, Michael A
Pain medicine (Malden, Mass.), 2017, Vol.18 (11), p.2170-2180
14.
Pharmacogenomics and Patient Treatment Parameters to Opioid Treatment in Chronic Pain: A Focus on Morphine, Oxycodone, Tramadol, and Fentanyl
by Lloyd, Renae A
Pain medicine (Malden, Mass.), 2017, Vol.18 (12), p.2369-2387
15.
Efficacy and safety of tapentadol prolonged release for moderate-to-severe chronic osteoarthritis knee pain: a pooled analysis of two double-blind, randomized, placebo- and oxycodo...
by Lange, Bernd
Current medical research and opinion, 2017, Vol.33 (8), p.1413-1422
16.
Innovative pain therapy with a fixed combination of prolonged-release oxycodone/naloxone: a large observational study under conditions of daily practice
by Schutter, U
Current medical research and opinion, 2010, Vol.26 (6), p.1377-1387
17.
Efficacy and tolerability of once-daily OROS® hydromorphone and twice-daily extended-release oxycodone in patients with chronic, moderate to severe osteoarthritis pain: Results of...
by Hale, Martin, MD
Clinical therapeutics, 2007, Vol.29 (5), p.874-888
18.
Effect of prolonged-released oxycodone/naloxone in postoperative pain management after total knee replacement: a nonrandomized prospective trial
by Oppermann, Johannes, MD
Journal of clinical anesthesia, 2016, Vol.33, p.491-497
19.
Meeting the Challenges of Opioid-Induced Constipation in Chronic Pain Management – A Novel Approach
by Reimer, Karen
Pharmacology, 2008, Vol.83 (1), p.10-17
20.
Evaluation of the durability of pain relief throughout a 12 hour dosing interval of a novel, extended-release, abuse-deterrent formulation of oxycodone
by Nalamachu, Srinivas
Current medical research and opinion, 2016, Vol.32 (7), p.1311-1317
